Comparative study of midazolam, dexmedetomidine, and ketamine as an adjuvant to lidocaine in intravenous regional anesthesia for forearm and hand surgeries

Background Intravenous regional anesthesia (IVRA) is an ideal method of providing anesthesia for minor surgical procedures to the extremities performed on an ambulatory basis. This study aimed to study the effects of adding midazolam, dexmedetomidine, or ketamine as an adjuvant to lidocaine in IVRA...

Full description

Bibliographic Details
Main Authors: Alaa E Mahmoud, Abdelwahab A Saleh, Ali A Mahareak, Ali A Alkumity
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Al-Azhar Assiut Medical Journal
Subjects:
Online Access:http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2017;volume=15;issue=3;spage=127;epage=134;aulast=Mahmoud
_version_ 1818579038312071168
author Alaa E Mahmoud
Abdelwahab A Saleh
Ali A Mahareak
Ali A Alkumity
author_facet Alaa E Mahmoud
Abdelwahab A Saleh
Ali A Mahareak
Ali A Alkumity
author_sort Alaa E Mahmoud
collection DOAJ
description Background Intravenous regional anesthesia (IVRA) is an ideal method of providing anesthesia for minor surgical procedures to the extremities performed on an ambulatory basis. This study aimed to study the effects of adding midazolam, dexmedetomidine, or ketamine as an adjuvant to lidocaine in IVRA during forearm and hand surgeries and examine their benefits and complications. Patients and methods A total of 120 patients were included, aged 40–60 years (American Society of Anesthesiologists physical status I–II), undergoing hand and forearm, from April 2015 to August 2016. Patients were randomly divided into four equal groups. Lidocaine-only group (LL group) received IVRA using 40 ml of lidocaine 0.5% (3 mg/kg). Lidocaine plus midazolam group (LM group) received IVRA using 40 ml of lidocaine 0.5% (3 mg/kg) plus midazolam 50 µg/kg added as an adjuvant. Lidocaine plus dexmedetomidine group (LD group) received IVRA using 40 ml of lidocaine 0.5% (3 mg/kg) plus dexmedetomidine 1 µg/kg added as an adjuvant. Lidocaine plus ketamine group (LK group) received IVRA using 40 ml of lidocaine 0.5% (3 mg/kg) plus ketamine 0.5 mg/kg added as an adjuvant. The time of onset, duration, and quality of analgesia; levels of sensory and motor block; heart rate; mean arterial blood pressure; and visual analog score were recorded. Adverse effects of hematoma, injection pain, skin erythema, sedation, and hallucinations were recorded. Results The onset time of sensory and motor blocks was significantly shorter in the adjuvant groups LM, LD, LK in comparison with the control group LL. The grade of sensory and motor blocks was significantly better in groups LM, LD, and LK in comparison with the LL group. The onset time of tourniquet pain was significantly shorter in the control group LL in comparison with adjuvant groups LM, LD, and LK. There was a significant increase in fentanyl requirements in the control LL group compared with adjuvant LM, LD, and LK groups. The duration of postoperative analgesia was significantly prolonged in adjuvant groups LM, LD, and LK compared with the control LL group. Hematoma, injection pain, cutaneous erythema, and hallucination were reported as postoperative complications. Conclusion The addition of midazolam, dexmedetomidine, or ketamine to lidocaine for IVRA improved the quality of intraoperative and postoperative analgesia with minimal adverse effects and higher patients and surgeon satisfaction.
first_indexed 2024-12-16T06:55:21Z
format Article
id doaj.art-c2db70ff6b6e4d759e7654e4c002b208
institution Directory Open Access Journal
issn 1687-1693
language English
last_indexed 2024-12-16T06:55:21Z
publishDate 2017-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Al-Azhar Assiut Medical Journal
spelling doaj.art-c2db70ff6b6e4d759e7654e4c002b2082022-12-21T22:40:18ZengWolters Kluwer Medknow PublicationsAl-Azhar Assiut Medical Journal1687-16932017-01-0115312713410.4103/AZMJ.AZMJ_32_17Comparative study of midazolam, dexmedetomidine, and ketamine as an adjuvant to lidocaine in intravenous regional anesthesia for forearm and hand surgeriesAlaa E MahmoudAbdelwahab A SalehAli A MahareakAli A AlkumityBackground Intravenous regional anesthesia (IVRA) is an ideal method of providing anesthesia for minor surgical procedures to the extremities performed on an ambulatory basis. This study aimed to study the effects of adding midazolam, dexmedetomidine, or ketamine as an adjuvant to lidocaine in IVRA during forearm and hand surgeries and examine their benefits and complications. Patients and methods A total of 120 patients were included, aged 40–60 years (American Society of Anesthesiologists physical status I–II), undergoing hand and forearm, from April 2015 to August 2016. Patients were randomly divided into four equal groups. Lidocaine-only group (LL group) received IVRA using 40 ml of lidocaine 0.5% (3 mg/kg). Lidocaine plus midazolam group (LM group) received IVRA using 40 ml of lidocaine 0.5% (3 mg/kg) plus midazolam 50 µg/kg added as an adjuvant. Lidocaine plus dexmedetomidine group (LD group) received IVRA using 40 ml of lidocaine 0.5% (3 mg/kg) plus dexmedetomidine 1 µg/kg added as an adjuvant. Lidocaine plus ketamine group (LK group) received IVRA using 40 ml of lidocaine 0.5% (3 mg/kg) plus ketamine 0.5 mg/kg added as an adjuvant. The time of onset, duration, and quality of analgesia; levels of sensory and motor block; heart rate; mean arterial blood pressure; and visual analog score were recorded. Adverse effects of hematoma, injection pain, skin erythema, sedation, and hallucinations were recorded. Results The onset time of sensory and motor blocks was significantly shorter in the adjuvant groups LM, LD, LK in comparison with the control group LL. The grade of sensory and motor blocks was significantly better in groups LM, LD, and LK in comparison with the LL group. The onset time of tourniquet pain was significantly shorter in the control group LL in comparison with adjuvant groups LM, LD, and LK. There was a significant increase in fentanyl requirements in the control LL group compared with adjuvant LM, LD, and LK groups. The duration of postoperative analgesia was significantly prolonged in adjuvant groups LM, LD, and LK compared with the control LL group. Hematoma, injection pain, cutaneous erythema, and hallucination were reported as postoperative complications. Conclusion The addition of midazolam, dexmedetomidine, or ketamine to lidocaine for IVRA improved the quality of intraoperative and postoperative analgesia with minimal adverse effects and higher patients and surgeon satisfaction.http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2017;volume=15;issue=3;spage=127;epage=134;aulast=Mahmouddexmedetomidineintravenous regional anesthesiaketaminelidocainemidazolam
spellingShingle Alaa E Mahmoud
Abdelwahab A Saleh
Ali A Mahareak
Ali A Alkumity
Comparative study of midazolam, dexmedetomidine, and ketamine as an adjuvant to lidocaine in intravenous regional anesthesia for forearm and hand surgeries
Al-Azhar Assiut Medical Journal
dexmedetomidine
intravenous regional anesthesia
ketamine
lidocaine
midazolam
title Comparative study of midazolam, dexmedetomidine, and ketamine as an adjuvant to lidocaine in intravenous regional anesthesia for forearm and hand surgeries
title_full Comparative study of midazolam, dexmedetomidine, and ketamine as an adjuvant to lidocaine in intravenous regional anesthesia for forearm and hand surgeries
title_fullStr Comparative study of midazolam, dexmedetomidine, and ketamine as an adjuvant to lidocaine in intravenous regional anesthesia for forearm and hand surgeries
title_full_unstemmed Comparative study of midazolam, dexmedetomidine, and ketamine as an adjuvant to lidocaine in intravenous regional anesthesia for forearm and hand surgeries
title_short Comparative study of midazolam, dexmedetomidine, and ketamine as an adjuvant to lidocaine in intravenous regional anesthesia for forearm and hand surgeries
title_sort comparative study of midazolam dexmedetomidine and ketamine as an adjuvant to lidocaine in intravenous regional anesthesia for forearm and hand surgeries
topic dexmedetomidine
intravenous regional anesthesia
ketamine
lidocaine
midazolam
url http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2017;volume=15;issue=3;spage=127;epage=134;aulast=Mahmoud
work_keys_str_mv AT alaaemahmoud comparativestudyofmidazolamdexmedetomidineandketamineasanadjuvanttolidocaineinintravenousregionalanesthesiaforforearmandhandsurgeries
AT abdelwahabasaleh comparativestudyofmidazolamdexmedetomidineandketamineasanadjuvanttolidocaineinintravenousregionalanesthesiaforforearmandhandsurgeries
AT aliamahareak comparativestudyofmidazolamdexmedetomidineandketamineasanadjuvanttolidocaineinintravenousregionalanesthesiaforforearmandhandsurgeries
AT aliaalkumity comparativestudyofmidazolamdexmedetomidineandketamineasanadjuvanttolidocaineinintravenousregionalanesthesiaforforearmandhandsurgeries